Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Induction therapy with paclitaxel and bevacizumab followed by switch maintenance therapy with eribulin in Japanese patients with HER2-negative metastatic breast cancer: a multicenter, collaborative, open-label, phase II clinical study for the SBCCSG 35 investigators.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request